Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cocrystal Pharma Inc shares valued at $18,812 were purchased by FROST PHILLIP MD ET AL on Nov 25 ’25. At $0.94 per share, FROST PHILLIP MD ET AL acquired 20,000 shares. The insider’s holdings grew to 1,699,551 shares worth approximately $1.72 million following the completion of this transaction.
As published in their initiating research note from H.C. Wainwright on July 08, 2020, Cocrystal Pharma Inc [COCP] has been a Buy and the price target has been revised to $5.
Analyzing COCP Stock Performance
On last trading session, Cocrystal Pharma Inc [NASDAQ: COCP] rose 7.25% to $1.01. The stock’s lowest price that day was $0.96, but it reached a high of $1.025 in the same session. During the last five days, there has been a surge of approximately 2.01%. Over the course of the year, Cocrystal Pharma Inc shares have dropped approximately -54.09%. Shares of the company reached a 52-week high of $2.6700 on 09/12/25 and a 52-week low of $0.9000 on 11/21/25.
Support And Resistance Levels for Cocrystal Pharma Inc (COCP)
According to the 24-hour chart, there is a support level at 0.9717, which, if violated, would cause prices to drop to 0.9333. In the upper region, resistance lies at 1.0367. The next price resistance is at 1.0633. RSI (Relative Strength Index) is 46.25 on the 14-day chart, showing neutral technical sentiment.
Is Cocrystal Pharma Inc subject to short interest?
Stocks of Cocrystal Pharma Inc saw a sharp steep in short interest on 2025-11-14 dropping by 71005.0 shares to 0.18 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 0.25 million shares. A decline of -40.25% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.06 of the overall float, the days-to-cover ratio (short ratio) decline to 1.06.
